| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
9,538,000
|
9,425,000
|
8,136,000
|
8,370,000
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
9,538,000
|
9,425,000
|
8,136,000
|
8,370,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 7,819,000 | 7,535,000 | 6,458,000 | 6,875,000 |
|
Non Recurring | 56,000 | 65,000 | 152,000 | 2,851,000 |
|
Others | 357,000 | 310,000 | 300,000 | 310,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
1,306,000
|
1,515,000
|
1,226,000
|
(1,666,000)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 2,463,000 | 1,437,000 | 1,406,000 | 29,000 |
|
Earnings Before Interest And Taxes | 3,926,000 | 3,126,000 | 2,822,000 | (1,374,000) |
|
Interest Expense | 276,000 | 266,000 | 267,000 | 261,000 |
|
Income Before Tax | 3,650,000 | 2,860,000 | 2,555,000 | (1,635,000) |
|
Income Tax Expense | 741,000 | 402,000 | 259,000 | (126,000) |
|
Minority Interest | (55,000) | (77,000) | (63,000) | (44,000) |
|
|
|
Net Income From Continuing Ops | 3,011,000 | 2,555,000 | 2,423,000 | (1,792,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
2,854,000
|
2,381,000
|
2,233,000
|
(1,553,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
2,854,000
|
2,381,000
|
2,233,000
|
(1,553,000)
|
|
0.04 (0.12%) 8:59AM EDT - Nasdaq Real Time Price